{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:29:26Z","timestamp":1762176566729},"publisher-location":"Berlin, Heidelberg","reference-count":23,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642814907"},{"type":"electronic","value":"9783642814884"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1980]]},"DOI":"10.1007\/978-3-642-81488-4_10","type":"book-chapter","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T05:37:49Z","timestamp":1323236269000},"page":"72-77","source":"Crossref","is-referenced-by-count":1,"title":["N-(Phosphonacetyl)-L-Aspartate (PALA): Current Status"],"prefix":"10.1007","author":[{"given":"M.","family":"Rozencweig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Abele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Piccart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. D.","family":"Von Hoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. M.","family":"Muggia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10_CR1","first-page":"182","volume":"19","author":"M Chadwick","year":"1978","unstructured":"Chadwick M, Silveira DM, MacGregor JA, Branfman AR, Liss RH, Yesair DW (1978) Physiological disposition of PALA in several species. Proc Am Assoc Cancer Res and Am Soc Clin Oncol 19:182","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR2","first-page":"241","volume":"20","author":"M Chadwick","year":"1979","unstructured":"Chadwick M, Silveira DM, McGarrigle PL, Liss RH, Schepis PJ (1979) Distribution of PALA in tissues and tumors of mice after intravenous administration. Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:241","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR3","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1016\/S0021-9258(19)34156-0","volume":"246","author":"KD Collins","year":"1971","unstructured":"Collins KD, Stark GR (1971) Aspartate transcarbamylase. Interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate. J Biol Chem 246:6599\u20136605","journal-title":"J Biol Chem"},{"key":"10_CR4","first-page":"1503","volume":"62","author":"DA Cooney","year":"1978","unstructured":"Cooney DA, Karlowicz MG, Cubillan J, Roettger M, Jayaram HN (1978) An enzymatic technique for measuring N-phosphonacetyl-L-aspartic acid in tissues. Cancer Treat Rep 62:1503\u20131507","journal-title":"Cancer Treat Rep"},{"key":"10_CR5","first-page":"185","volume":"20","author":"C Erlichman","year":"1979","unstructured":"Erlichman C, Chabner BA (1979) A competitive protein binding assay for N-phosphon-acetyl-L-aspartate (PALA). Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:185","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR6","first-page":"314","volume":"20","author":"C Erlichman","year":"1979","unstructured":"Erlichman C, Strong, J, Wiernick P, Edwards L, Cohen M, Levine A, Hubbard S, Chabner B (1979) Phase I trial of PALA (N-phosphonacetyl-L-aspartate). Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20: 314","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR7","first-page":"200","volume":"20","author":"TJ Ervin","year":"1979","unstructured":"Ervin, TJ, Blum RH, Canellos GP (1979) N-Phosphonacetyl-L-aspartate (PALA), phase I trial. Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:200","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR8","first-page":"85","volume":"63","author":"J Friedman","year":"1979","unstructured":"Friedman J, Moore EC, Hall SW, Loo TL (1979) Enzymatic assay for the antitumor agent N-(phosphonacetyl)-L-aspartic acid (PALA). Cancer Treat Rep 63:85\u201388","journal-title":"Cancer Treat Rep"},{"key":"10_CR9","first-page":"113","volume-title":"Advances in Medical Oncology, Research and Eduction, vol. 5, Basis for Cancer Therapy 1","author":"A Goldin","year":"1979","unstructured":"Goldin A, Venditti JM, Muggia FM, Rozencweig M, De Vita VT (1979) New animal models in cancer chemotherapy. In: Fox BW (ed.) Advances in Medical Oncology, Research and Eduction, vol. 5, Basis for Cancer Therapy 1. Pergamon Press, Oxford, pp 113\u2013122"},{"key":"10_CR10","first-page":"115","volume":"20","author":"RJ Gralla","year":"1979","unstructured":"Gralla RJ, Casper ES, Golbey RB, Young CW (1979) Phase I and preliminary phase II studies with N-(phosphonacetyl)-L-aspartic acid (PALA). Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:115","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR11","first-page":"1291","volume":"63","author":"HN Jayaram","year":"1979","unstructured":"Jayaram HN, Cooney DA, Vistica DT, Kariya S, Johnson RK (1979) Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate. Cancer Treat Rep 63:1291\u20131302","journal-title":"Cancer Treat Rep"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0006-2952(77)90137-X","volume":"26","author":"RK Johnson","year":"1977","unstructured":"Johnson RK (1977) Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-as- partate by uridine or carbamyl-DL-aspartate in vivo. Biochem Pharmacol 26:81\u201384","journal-title":"Biochem Pharmacol"},{"key":"10_CR13","first-page":"371","volume":"38","author":"RK Johnson","year":"1978","unstructured":"Johnson RK, Swyryd EA, Stark GR (1978) Effects of N-(phosphonacetyl)-L-aspartate on murine tumors and normal tissues in vivo and in vitro and the relationship of sensitivity to rate of proliferation and level of aspartate transcarbamylase. Cancer Res 38:371\u2013377","journal-title":"Cancer Res"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0092-8674(76)90036-2","volume":"9","author":"TD Kempe","year":"1976","unstructured":"Kempe TD, Swyryd EA, Bruist M, Stark GR (1976) Stable mutants of mammalian cells that overproduce the first three enzymes of pyrimidine nucleotide biosynthesis. Cell 9:541\u2013550","journal-title":"Cell"},{"key":"10_CR15","first-page":"243","volume":"20","author":"TW Kensler","year":"1979","unstructured":"Kensler TW, Jayaram HN, Cooney DA, Petrucci PE (1979) Inhibition of L-aspartate transcarbamylase (ATCase) in human leucocytes by N-(phosphonacetyl)-L-aspartic acid (PALA): Use of peripheral white blood cells as enzymic indicators. Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:243","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR16","first-page":"95","volume":"20","author":"WR Laster Jr","year":"1979","unstructured":"Laster WR Jr, Schabel FM Jr (1979) Collateral sensitivity of P388\/Ara-C and P388\/5-FU to N-(phosphonacetyl)-L-aspartate (PALA). Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:95","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR17","first-page":"221","volume":"20","author":"EC Moore","year":"1979","unstructured":"Moore EC, Friedman J, Valdivieso M, Marti JR, Russ J, Loo TL (1979) N-(Phosphono- acetyl)-L-aspartate (PALA) concentration and aspartate carbamoyltransferase (ACTase) activity in biopsy specimens of patients treated with PALA. Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:221","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR18","first-page":"63","volume":"19","author":"R Nayak","year":"1978","unstructured":"Nayak R, Martin D, Stolfi R, Furth J, Spiegelman S (1978) Pyrimidine nucleosides enhance the anti-cancer activity of FU and augment its incorporation into nuclear RNA. Proc Am Assoc Cancer Res and Am Soc Clin Oncol 19:63","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR19","first-page":"344","volume":"20","author":"T Ohnuma","year":"1979","unstructured":"Ohnuma T, Hart R, Roboz J, Andrejczuk A, Holland JF (1979) Clinical and pharmacological studies with phosphonoacetyl-L-aspartate (PALA). Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:344","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"},{"key":"10_CR20","first-page":"984","volume":"48","author":"M Rozencweig","year":"1976","unstructured":"Rozencweig M, Von Hoff DD, Venditti JM, Muggia FM (1976) Correlation between experimental activity of anticancer agents and their hematologic toxicity in man. Blood 48:984","journal-title":"Blood"},{"key":"10_CR21","first-page":"15","volume-title":"Lung cancer: Progress in therapeutic research","author":"FM Schabel Jr","year":"1979","unstructured":"Schabel FM Jr, Laster WR Jr, Rose WC (1979) The role of experimental tumor systems. In: Muggia FM, Rozencweig M (eds) Lung cancer: Progress in therapeutic research. Raven, New York, pp 15\u201335"},{"key":"10_CR22","first-page":"775","volume":"63","author":"JM Strong","year":"1979","unstructured":"Strong JM, Kinney YE, Branfman AR, Cysyk RL (1979) Determination of N-(phos- phonacetyl)-L-aspartic acid (PALA) in dog serum and urine by gas chromatography and selected ion monitoring. Cancer Treat Rep 63: 775\u2013780","journal-title":"Cancer Treat Rep"},{"key":"10_CR23","first-page":"187","volume":"20","author":"M Valdivieso","year":"1979","unstructured":"Valdivieso M, Moore EC, Loo TL, Bodey GP, Freireich EJ (1979) Phase I clinical study of N-(phosphonoacetyl)-L-aspartate (PALA, NSC 224131). Proc Am Assoc Cancer Res and Am Soc Clin Oncol 20:187","journal-title":"Proc Am Assoc Cancer Res and Am Soc Clin Oncol"}],"container-title":["Recent Results in Cancer Research","Cancer Chemo- and Immunopharmacology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-81488-4_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T03:12:27Z","timestamp":1639883547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-81488-4_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980]]},"ISBN":["9783642814907","9783642814884"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-81488-4_10","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1980]]}}}